198 related articles for article (PubMed ID: 26972296)
1. New Frontiers in Promoting TRAIL-Mediated Cell Death: Focus on Natural Sensitizers, miRNAs, and Nanotechnological Advancements.
Farooqi AA; Gadaleta CD; Ranieri G; Fayyaz S; Marech I
Cell Biochem Biophys; 2016 Mar; 74(1):3-10. PubMed ID: 26972296
[TBL] [Abstract][Full Text] [Related]
2. Editorial.
Farooqi AA; Ismail M
Cell Mol Biol (Noisy-le-grand); 2015 Oct; 61(6):1. PubMed ID: 26520390
[TBL] [Abstract][Full Text] [Related]
3. Natural Product Mediated Regulation of Death Receptors and Intracellular Machinery: Fresh from the Pipeline about TRAIL-Mediated Signaling and Natural TRAIL Sensitizers.
Shahwar D; Iqbal MJ; Nisa MU; Todorovska M; Attar R; Sabitaliyevich UY; Farooqi AA; Ahmad A; Xu B
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31022877
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA regulation of TRAIL mediated signaling in different cancers: Control of micro steering wheels during the journey from bench-top to the bedside.
Fayyaz S; Javed Z; Attar R; Farooqi AA; Yaylim I; Ahmad A
Semin Cancer Biol; 2019 Oct; 58():56-64. PubMed ID: 30716480
[TBL] [Abstract][Full Text] [Related]
5. Restoring TRAIL mediated signaling in ovarian cancer cells.
Farooqi AA; Yaylim I; Ozkan NE; Zaman F; Halim TA; Chang HW
Arch Immunol Ther Exp (Warsz); 2014 Dec; 62(6):459-74. PubMed ID: 25030086
[TBL] [Abstract][Full Text] [Related]
6. TRAIL mediated signaling as a double-edged sword in pancreatic cancer: Analysis of brighter and darker sides of the pathway.
Farooqi AA; Zahid R; Maryam A; Naureen H; Attar R; Sabitaliyevich UY; Konysbayevna KK
Cell Mol Biol (Noisy-le-grand); 2020 Jun; 66(3):215-220. PubMed ID: 32538774
[TBL] [Abstract][Full Text] [Related]
7. The biological complexity of RKIP signaling in human cancers.
Farooqi AA; Li Y; Sarkar FH
Exp Mol Med; 2015 Sep; 47(9):e185. PubMed ID: 26403261
[TBL] [Abstract][Full Text] [Related]
8. Dealing naturally with stumbling blocks on highways and byways of TRAIL induced signaling.
Rana A; Attar R; Qureshi MZ; Gasparri ML; Donato VD; Ali GM; Farooqi AA
Asian Pac J Cancer Prev; 2014; 15(19):8041-6. PubMed ID: 25338981
[TBL] [Abstract][Full Text] [Related]
9. TRAIL mediated signaling in different cancers: cancer in the "Crosshairs".
Farooqi AA; Naureen H; Yilmaz S; Sabitaliyevich UY; Zhailganov A; Rabandiyarov M; Ucak I; Karasholakova L; Attar R
Cell Mol Biol (Noisy-le-grand); 2020 Dec; 66(8):1-8. PubMed ID: 34174975
[TBL] [Abstract][Full Text] [Related]
10. MicroRNAs in cancer cell death pathways: Apoptosis and necroptosis.
Shirjang S; Mansoori B; Asghari S; Duijf PHG; Mohammadi A; Gjerstorff M; Baradaran B
Free Radic Biol Med; 2019 Aug; 139():1-15. PubMed ID: 31102709
[TBL] [Abstract][Full Text] [Related]
11. Natural products are the future of anticancer therapy: Preclinical and clinical advancements of Viscum album phytometabolites.
Attar R; Tabassum S; Fayyaz S; Ahmad MS; Nogueira DR; Yaylim I; Timirci-Kahraman O; Kucukhuseyin O; Cacina C; Farooqi AA; Ismail M
Cell Mol Biol (Noisy-le-grand); 2015 Oct; 61(6):62-8. PubMed ID: 26518897
[TBL] [Abstract][Full Text] [Related]
12. TRAIL as a target in anti-cancer therapy.
Wu GS
Cancer Lett; 2009 Nov; 285(1):1-5. PubMed ID: 19299078
[TBL] [Abstract][Full Text] [Related]
13. TRAIL based therapy: overview of mesenchymal stem cell based delivery and miRNA controlled expression of TRAIL.
Attar R; Sajjad F; Qureshi MZ; Tahir F; Hussain E; Fayyaz S; Farooqi AA
Asian Pac J Cancer Prev; 2014; 15(16):6495-7. PubMed ID: 25169476
[TBL] [Abstract][Full Text] [Related]
14. Genetic variants in the tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) do not contribute but Death Receptor (DR4) genes may contribute to susceptibility to head and neck cancer in Pakistani population.
Sarwar R; Mansoor Q; Farooqi AA; Shahzad S; Fayyaz S; Ismail M
Cell Mol Biol (Noisy-le-grand); 2015 Dec; 61(8):53-6. PubMed ID: 26718429
[TBL] [Abstract][Full Text] [Related]
15. While at Rome miRNA and TRAIL do whatever BCR-ABL commands to do.
Farooqi AA; Nawaz A; Javed Z; Bhatti S; Ismail M
Arch Immunol Ther Exp (Warsz); 2013 Feb; 61(1):59-74. PubMed ID: 23229677
[TBL] [Abstract][Full Text] [Related]
16. Targeting microRNAs to modulate TRAIL-induced apoptosis of cancer cells.
Lu T; Shao N; Ji C
Cancer Gene Ther; 2013 Jan; 20(1):33-7. PubMed ID: 23138871
[TBL] [Abstract][Full Text] [Related]
17. TNF-related apoptosis-inducing ligand (TRAIL): a new path to anti-cancer therapies.
Holoch PA; Griffith TS
Eur J Pharmacol; 2009 Dec; 625(1-3):63-72. PubMed ID: 19836385
[TBL] [Abstract][Full Text] [Related]
18. TRAIL and Bortezomib: killing cancer with two stones.
Qureshi MZ; Romero MA; Attar R; Javed Z; Farooqi AA
Asian Pac J Cancer Prev; 2015; 16(4):1671-4. PubMed ID: 25743849
[TBL] [Abstract][Full Text] [Related]
19. Downmodulation of dimethyl transferase activity enhances tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in prostate cancer cells.
Festuccia C; Gravina GL; D'Alessandro AM; Millimaggi D; Di Rocco C; Dolo V; Ricevuto E; Vicentini C; Bologna M
Int J Oncol; 2008 Aug; 33(2):381-8. PubMed ID: 18636160
[TBL] [Abstract][Full Text] [Related]
20. TRAIL and microRNAs in the treatment of prostate cancer: therapeutic potential and role of nanotechnology.
Farooqi AA; De Rosa G
Appl Microbiol Biotechnol; 2013 Oct; 97(20):8849-57. PubMed ID: 24037407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
